Related Experiment Videos
Current Management Practices in Ménière's Disease
Joseph W Clyde1, Benjamin S Oberman, Huseyin Isildak
1*College of Medicine †Division of Otolaryngology-Head and Neck Surgery, Department of Surgery, College of Medicine, The Pennsylvania State University, Hershey, Pennsylvania.
Summary
Treatment for Ménière
Area of Science:
- Otolaryngology
- Neurology
- Clinical Medicine
Background:
- Ménière's disease (MD) is a complex inner ear disorder.
- Current management strategies for MD vary significantly among otolaryngologists.
- Understanding these trends is crucial for improving patient care.
Purpose of the Study:
- To evaluate current trends in Ménière's disease management.
- To compare treatment modalities used by general otolaryngologists and otologists/neurotologists.
- To identify variations in therapeutic approaches.
Main Methods:
- Cross-sectional study utilizing an electronic questionnaire.
- Survey disseminated to members of the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS).
- Analysis of responses from 860 physicians, including generalists and neurotologists.
Main Results:
- Significant differences exist in treatment preferences between generalists and neurotologists.
- Neurotologists more frequently use intratympanic steroids and endolymphatic sac procedures.
- Hydrochlorothiazide/triamterene is commonly used by both groups, with neurotologists using it more often.
Conclusions:
- There is substantial heterogeneity in Ménière's disease treatment among otolaryngologists.
- Neurotologists employ a broader range of medications and surgical interventions.
- A standardized guideline for MD treatment, including dosing and escalation, is needed.